GMPR2
GMP reductase 2
Also known as: GMPR2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9P2T1
- Gene
- GMPR2
- Ensembl
- ENSG00000100938
- Chromosome
- 14
- Canonical length
- 348 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes an enzyme that catalyzes the irreversible and NADPH-dependent reductive deamination of guanosine monophosphate (GMP) to inosine monophosphate (IMP). The protein also functions in the re-utilization of free intracellular bases and purine nucleosides. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2017]
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>Q9P2T1|GMPR2
1 MPHIDNDVKL DFKDVLLRPK RSTLKSRSEV DLTRSFSFRN SKQTYSGVPI IAANMDTVGT
61 FEMAKVLCKF SLFTAVHKHY SLVQWQEFAG QNPDCLEHLA ASSGTGSSDF EQLEQILEAI
121 PQVKYICLDV ANGYSEHFVE FVKDVRKRFP QHTIMAGNVV TGEMVEELIL SGADIIKVGI
181 GPGSVCTTRK KTGVGYPQLS AVMECADAAH GLKGHIISDG GCSCPGDVAK AFGAGADFVM
241 LGGMLAGHSE SGGELIERDG KKYKLFYGMS SEMAMKKYAG GVAEYRASEG KTVEVPFKGD
301 VEHTIRDILG GIRSTCTYVG AAKLKELSRR TTFIRVTQQV NPIFSEACLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GMPR2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 90 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 90 nTPM
- kidney: 75 nTPM
- parathyroid gland: 64 nTPM
- blood vessel: 60 nTPM
- thyroid gland: 58 nTPM
- spleen: 55 nTPM
Single-cell type
- other brain neurons: 14 nCPM
- oligodendrocytes: 13 nCPM
- microglia: 12 nCPM
- brain inhibitory neurons: 10 nCPM
- astrocytes: 10 nCPM
- bergmann glia: 10 nCPM
Immune cell
- neutrophil: 56 nTPM
- myeloid DC: 36 nTPM
- classical monocyte: 34 nTPM
- T-reg: 31 nTPM
- non-classical monocyte: 28 nTPM
- intermediate monocyte: 27 nTPM
Brain region
- choroid plexus: 20 nTPM
- pons: 17 nTPM
- medulla oblongata: 17 nTPM
- thalamus: 16 nTPM
- white matter: 16 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.8
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GMPR2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GMPR2 as an antibody target. Whether an autoantibody or antibody against GMPR2 could matter depends on whether native GMPR2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GMPR2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label GMPR2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...